Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and supplemented as follows: As previously disclosed, on May 21, 2025, CapitalSpring entered into a Confidentiality Agreement with the Issuer. Also on May 21, 2025, WKS Corporation entered into a substantially similar confidentiality agreement with the Issuer (the "WKS Confidentiality Agreement"), a copy of which is attached hereto as Exhibit 4 and incorporated by reference into this Item 4. Representatives of CapitalSpring have continued to engage in discussions with the Issuer's management and other third parties, including WKS Corporation, with regard to a potential extraordinary transaction involving the Issuer and other third parties, with which CapitalSpring and WKS Corporation may participate, together or separately, as investors, financing sources, or otherwise. There is no assurance that any such transaction will develop or materialize, or if it does, as to its timing or whether the Reporting Persons will participate. The Reporting Persons expect to continuously review their investment in the Issuer. Except as indicated herein, no Reporting Person, as a stockholder of the Issuer, has any plans or proposals that relates or would result in any of the transactions or other matters specified in clauses (a) though (j) of Item 4 of Schedule 13D. Each Reporting Person may, at any time and from time to time, review or reconsider its or his position and/or change its or his purpose and/or formulate plans or proposals with respect thereto.